Integer Holdings Corporation (NYSE:ITGR) Receives $97.25 Consensus PT from Brokerages

Shares of Integer Holdings Corporation (NYSE:ITGR) have been assigned a consensus rating of “Hold” from the eleven brokerages that are covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $97.25.

A number of equities analysts have issued reports on ITGR shares. Raymond James Financial reiterated an “outperform” rating and issued a $95.00 price objective (down previously from $143.00) on shares of Integer in a report on Friday, October 24th. Citigroup increased their price target on shares of Integer from $69.00 to $75.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Wells Fargo & Company reissued an “equal weight” rating and set a $80.00 price target (down from $132.00) on shares of Integer in a research report on Friday, October 24th. Argus cut shares of Integer from a “buy” rating to a “hold” rating in a report on Friday, October 24th. Finally, Truist Financial decreased their target price on shares of Integer from $88.00 to $86.00 and set a “buy” rating for the company in a research note on Monday, November 24th.

Insider Buying and Selling

In other Integer news, VP Tommy P. Thomas sold 884 shares of the business’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $70.15, for a total value of $62,012.60. Following the sale, the vice president directly owned 3,596 shares of the company’s stock, valued at approximately $252,259.40. The trade was a 19.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Diron Smith purchased 1,116 shares of Integer stock in a transaction dated Friday, November 7th. The shares were bought at an average price of $67.19 per share, with a total value of $74,984.04. Following the completion of the acquisition, the executive vice president directly owned 7,698 shares of the company’s stock, valued at approximately $517,228.62. This represents a 16.96% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 5,843 shares of company stock worth $384,771 over the last three months. 2.16% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of ITGR. Mirabella Financial Services LLP purchased a new stake in shares of Integer during the third quarter valued at approximately $274,000. Tudor Investment Corp ET AL lifted its position in Integer by 50,787.5% in the 3rd quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock valued at $28,606,000 after acquiring an additional 29,442,029 shares in the last quarter. CIBC Bancorp USA Inc. purchased a new stake in Integer during the 3rd quarter valued at $380,000. CANADA LIFE ASSURANCE Co increased its holdings in shares of Integer by 1.7% in the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 29,629 shares of the medical equipment provider’s stock worth $2,996,000 after purchasing an additional 502 shares in the last quarter. Finally, Qube Research & Technologies Ltd raised its stake in shares of Integer by 668.6% in the third quarter. Qube Research & Technologies Ltd now owns 93,935 shares of the medical equipment provider’s stock worth $9,706,000 after purchasing an additional 81,713 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Price Performance

ITGR stock opened at $74.14 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45. Integer has a 1 year low of $62.00 and a 1 year high of $146.36. The firm has a 50-day moving average of $77.42 and a 200 day moving average of $99.34. The company has a market cap of $2.60 billion, a P/E ratio of 31.02, a PEG ratio of 0.67 and a beta of 0.82.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share for the quarter, beating the consensus estimate of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.During the same quarter in the previous year, the business posted $1.43 EPS. The business’s revenue was up 8.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. On average, sell-side analysts forecast that Integer will post 6.01 EPS for the current year.

Integer announced that its board has authorized a stock repurchase program on Tuesday, November 4th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the medical equipment provider to reacquire up to 8.3% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s leadership believes its stock is undervalued.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.